Package 68727-150-01

{"route": ["ORAL"], "spl_id": "6815ce2b-51e5-4d03-92a6-523718ab0d8c", "openfda": {"unii": ["8W24SYD6ZI", "G983HLV265", "S8NKF3H3KT", "7G33012534"], "rxcui": ["2393794", "2393795"], "spl_set_id": ["1e0ae43a-037f-42af-8e23-a0e51d75abe8"], "manufacturer_name": ["Jazz Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "180 mL in 1 BOTTLE, PLASTIC (68727-150-01)", "package_ndc": "68727-150-01", "marketing_start_date": "20201102"}], "brand_name": "XYWAV", "product_id": "68727-150_6815ce2b-51e5-4d03-92a6-523718ab0d8c", "dosage_form": "SOLUTION", "pharm_class": ["Central Nervous System Depressant [EPC]", "Central Nervous System Depressant [EPC]", "Central Nervous System Depressant [EPC]", "Central Nervous System Depressant [EPC]", "Central Nervous System Depression [PE]", "Central Nervous System Depression [PE]", "Central Nervous System Depression [PE]", "Central Nervous System Depression [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]"], "product_ndc": "68727-150", "dea_schedule": "CIII", "generic_name": "calcium, magnesium, potassium, and sodium oxybates", "labeler_name": "Jazz Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XYWAV", "active_ingredients": [{"name": "CALCIUM OXYBATE", "strength": ".5 g/mL"}, {"name": "MAGNESIUM OXYBATE", "strength": ".5 g/mL"}, {"name": "POTASSIUM OXYBATE", "strength": ".5 g/mL"}, {"name": "SODIUM OXYBATE", "strength": ".5 g/mL"}], "application_number": "NDA212690", "marketing_category": "NDA", "marketing_start_date": "20201102", "listing_expiration_date": "20261231"}